Tumor organoid–T-cell coculture systems-Reference-Cited by-同舟云学术

Tumor organoid–T-cell coculture systems

Published:2019-12-18 Issue:1 Volume:15 Page:15-39
ISSN:1754-2189
Container-title:Nature Protocols
language:en
Short-container-title:Nat Protoc

Author:

Cattaneo Chiara M.,Dijkstra Krijn K.,Fanchi Lorenzo F.,Kelderman Sander,Kaing Sovann,van Rooij Nienke,van den Brink Stieneke,Schumacher Ton N.,Voest Emile E.

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology

Link

http://www.nature.com/articles/s41596-019-0232-9.pdf

Reference31 articles.

1. Blank, C. U., Haanen, J. B., Ribas, A. & Schumacher, T. N. The “cancer immunogram”. Science 352, 658–660 (2016).

2. Dijkstra, K. K., Voabil, P., Schumacher, T. N. & Voest, E. E. Genomics- and transcriptomics-based patient selection for cancer treatment with immune checkpoint inhibitors: a review. JAMA Oncol. 2, 1490–1495 (2016).

3. Pitt, J. M. et al. Resistance mechanisms to immune-checkpoint blockade in cancer: tumor-intrinsic and -extrinsic factors. Immunity 44, 1255–1269 (2016).

4. Sharma, P., Hu-Lieskovan, S., Wargo, J. A. & Ribas, A. Primary, adaptive, and acquired resistance to cancer immunotherapy. Cell 168, 707–723 (2017).

5. Turcotte, S. et al. Phenotype and function of T cells infiltrating visceral metastases from gastrointestinal cancers and melanoma: implications for adoptive cell transfer therapy. J. Immunol. 191, 2217–2225 (2013).

Cited by 224 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DC-derived CXCL10 promotes CTL activation to suppress ovarian cancer;Translational Research;2024-10

2. Challenges in validation of combination treatment strategies for CRC using patient-derived organoids;Journal of Experimental & Clinical Cancer Research;2024-09-11

3. Recapitulating the Cancer‐Immunity Cycle on a Chip;Advanced Healthcare Materials;2024-09-02

4. Early-onset cancers: Biological bases and clinical implications;Cell Reports Medicine;2024-09

5. Activation and antitumor immunity of CD8 ⁺ T cells are supported by the glucose transporter GLUT10 and disrupted by lactic acid;Science Translational Medicine;2024-08-28